Therma Bright Inc.

THRM

CA8834261080

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 12:44:30 09/07/2024 am IST			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-25.00%	-40.00%

28/06	Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
21/06	Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement	MT

Therma Bright Inc. Appoints Ian Levine to the Advisory Board

January 15, 2021 at 05:51 pm IST

Therma Bright Inc. announced the appointment of Ian Levine to the advisory board to assist with future scaling for the manufacture of CoviSafe™.

Latest news about Therma Bright Inc.

Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	29/06	CI
Therma Bright Completes Second, Final Tranche of Fully Subscribed Non-Brokered Private Placement	21/06	MT
Therma Bright Inc. announced that it has received CAD 1 million in funding	21/06	CI
Therma Bright Inc. announced that it expects to receive CAD 1 million in funding	22/05	CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	02/04	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	10/01	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	05/01	CI
Ontario Securities Commission Issues Cease Trade Order Against Therma Bright Inc	06/12	CI
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer	29/11	CI
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States	02/11	CI
Therma Bright Inc. Announces Chief Financial Officer Changes	30/23/30	CI
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device	13/23/13	CI
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description	07/23/07	CI
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region	30/23/30	CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	29/23/29	CI
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device	08/23/08	CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	04/23/04	CI
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc	23/23/23	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	23/22/23	CI
Therma Bright Inc. Auditor Raises 'Going Concern' Doubt	28/22/28	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	28/22/28	CI
Therma Bright Agrees to Buy Exclusive License for Patented Digital Cough-Based Technology to Detect Respiratory Diseases	18/22/18	MT
Therma Bright Receives Payment for Initial Venowave Sales	20/22/20	CI
Therma Bright Inc. Provides Update on FDA EUA Review Process	12/22/12	CI
Therma Bright Inc. Provides Updates on Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test	04/22/04	CI

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.

Sector

Advanced Medical Equipment & Technology

Calendar

07/04/2025 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMA BRIGHT INC.	-40.00%	6.17M
THERMO FISHER SCIENTIFIC	+1.04%	206B
DANAHER CORPORATION	+4.02%	177B
INTUITIVE SURGICAL, INC.	+31.77%	157B
BOSTON SCIENTIFIC CORPORATION	+31.66%	112B
SIEMENS HEALTHINEERS AG	+1.56%	64.63B
EDWARDS LIFESCIENCES CORPORATION	+20.45%	55.63B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.54%	47.57B
AGILENT TECHNOLOGIES, INC.	-9.32%	36.87B
GE HEALTHCARE TECHNOLOGIES INC.	-1.25%	35.18B